Delivery Order SPE2DB22D3301-SPE2DB25FY2YG
Award Date
4/8/25
Potential Completion Date
4/9/25
Potential Value
$6.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,412.67, is for the delivery of ABILIFY MAINTENA ER 300 MG SYRS, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,850.36 firm fixed-price contract is for the delivery of ABILIFY MAINTENA ER 400 MG SYRS, a specialty pharmaceutical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The award is for the supply of Abilify Maintena ER 400 mg vials, a specialty brand name medication, with a potential value of $5,016.99 and a completion date of February 2, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves...
This federal contract award, valued at $1,842.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Abilify Maintena ER 400 mg syringes, a medication used to treat certain mental health conditions. The contract is not a set-aside and represents an open competition. It has an ultimate completion date of April 29, 2025. AmerisourceBergen Drug...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,714.54 for the supply of Abilify Maintena Extended-Release (ER) 400 mg syringes. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 24, 2024. The contract is a firm-fixed-price delivery order, which is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $10,608.25 firm-fixed-price delivery order is for the supply of ABILIFY MAINTENA ER 400 MG VLS medication. The delivery order has an ultimate completion date of August 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Abilify Maintena ER 400 mg vials. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with an ultimate completion date of August 23, 2024 and a ceiling value of $2,471.47. The contract does not have a set-aside designation. Amerisourcebergen, through its Corporate Office Division, has been a long-standing supplier of...
This federal contract award is for the delivery of Abilify Maintena ER 400 mg vials to the Defense Logistics Agency (DLA). The $8,728.64 contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company owned by the parent organization Cencora, Inc. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,308.30, is for the delivery of Abilify ER 400mg syringes. It is a firm fixed-price contract with a performance period ending on May 28, 2025. The contract is not set-aside and was openly competed. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
The Defense Logistics Agency awarded a $6,429.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 milligram injections of ABILIFY MAINTENA. As the prime contractor, Amerisourcebergen will supply the atypical antipsychotic medication to support DLA programs. Performance will occur at Amerisourcebergen's Conshohocken, Pennsylvania facility from July 7-10, 2023. No subcontractors or set aside designations were identified. This order is likely associated with DLA's...